186 related articles for article (PubMed ID: 2369083)
21. Antitumor activity and mechanism of action of different antiprogestins in experimental breast cancer models.
Schneider MR; Michna H; Nishino Y; el Etreby MF
J Steroid Biochem Mol Biol; 1990 Dec; 37(6):783-7. PubMed ID: 2285591
[TBL] [Abstract][Full Text] [Related]
22. Mechanism of growth inhibition of mammary carcinomas by glucarate and the glucarate: retinoid combination.
Webb TE; Abou-Issa H; Stromberg PC; Curley RC; Nguyen MH
Anticancer Res; 1993; 13(6A):2095-9. PubMed ID: 8297119
[TBL] [Abstract][Full Text] [Related]
23. Idoxifene antagonizes estradiol-dependent MCF-7 breast cancer xenograft growth through sustained induction of apoptosis.
Johnston SR; Boeddinghaus IM; Riddler S; Haynes BP; Hardcastle IR; Rowlands M; Grimshaw R; Jarman M; Dowsett M
Cancer Res; 1999 Aug; 59(15):3646-51. PubMed ID: 10446976
[TBL] [Abstract][Full Text] [Related]
24. Effects of the antiestrogen tamoxifen and the aromatase inhibitor letrozole on serum hormones and bone characteristics in a preclinical tumor model for breast cancer.
Núñez NP; Jelovac D; Macedo L; Berrigan D; Perkins SN; Hursting SD; Barrett JC; Brodie A
Clin Cancer Res; 2004 Aug; 10(16):5375-80. PubMed ID: 15328175
[TBL] [Abstract][Full Text] [Related]
25. A-ring substituted estrogens as inhibitors of the MXT transplantable mammary ductal carcinoma.
Brooks SC; Horwitz JP; Odden D; Corbett T
Cancer Res; 1987 Sep; 47(17):4623-9. PubMed ID: 3040228
[TBL] [Abstract][Full Text] [Related]
26. Natural and synthetic progestins accelerate 7,12-dimethylbenz[a]anthracene-initiated mammary tumors and increase angiogenesis in Sprague-Dawley rats.
Benakanakere I; Besch-Williford C; Schnell J; Brandt S; Ellersieck MR; Molinolo A; Hyder SM
Clin Cancer Res; 2006 Jul; 12(13):4062-71. PubMed ID: 16818706
[TBL] [Abstract][Full Text] [Related]
27. [In vitro study of estradiol-linked nitrosourea in breast cancers in the mouse, rat and human: interspecies comparison].
Petru E; Berger MR; Zeller WJ; Kaufmann M
Wien Klin Wochenschr; 1989 Feb; 101(4):130-4. PubMed ID: 2538970
[TBL] [Abstract][Full Text] [Related]
28. [Hormone independent murine carcinoma BX-1 spontaneously arising from nude mouse bearing Br-10, a hormone dependent human breast carcinoma strain].
Kubota T; Oka S; Utsumi T; Enomoto K; Ishibiki K; Abe O; Koh J; Shiina E; Asanuma F; Yamada Y
Gan To Kagaku Ryoho; 1988 Jul; 15(7):2081-6. PubMed ID: 3395136
[TBL] [Abstract][Full Text] [Related]
29. Effects of a new clinically relevant antiestrogen (GW5638) related to tamoxifen on breast and endometrial cancer growth in vivo.
Dardes RC; O'Regan RM; Gajdos C; Robinson SP; Bentrem D; De Los Reyes A; Jordan VC
Clin Cancer Res; 2002 Jun; 8(6):1995-2001. PubMed ID: 12060645
[TBL] [Abstract][Full Text] [Related]
30. Effect of aromatase inhibitors on growth of mammary tumors in a nude mouse model.
Yue W; Wang J; Savinov A; Brodie A
Cancer Res; 1995 Jul; 55(14):3073-7. PubMed ID: 7606729
[TBL] [Abstract][Full Text] [Related]
31. [Transplantation of in vitro cultured human tumors to nude mice and their use as chemotherapeutic test models].
Naundorf B; Arnold W; Nissen E; Wildner GP
Folia Haematol Int Mag Klin Morphol Blutforsch; 1981; 108(5):652-7. PubMed ID: 6172329
[No Abstract] [Full Text] [Related]
32. Dietary genistein results in larger MNU-induced, estrogen-dependent mammary tumors following ovariectomy of Sprague-Dawley rats.
Allred CD; Allred KF; Ju YH; Clausen LM; Doerge DR; Schantz SL; Korol DL; Wallig MA; Helferich WG
Carcinogenesis; 2004 Feb; 25(2):211-8. PubMed ID: 14578162
[TBL] [Abstract][Full Text] [Related]
33. Growth inhibition in response to estrogen withdrawal and tamoxifen therapy of human breast cancer xenografts evaluated by in vivo 31P magnetic resonance spectroscopy, creatine kinase activity, and apoptotic index.
Kristensen CA; Kristjansen PE; Brünner N; Quistorff B; Spang-Thomsen M
Cancer Res; 1995 Sep; 55(18):4146-50. PubMed ID: 7664292
[TBL] [Abstract][Full Text] [Related]
34. Hormone-dependent mammary tumors in mice and rats as a model for human breast cancer (review).
Briand P
Anticancer Res; 1983; 3(4):273-81. PubMed ID: 6309070
[TBL] [Abstract][Full Text] [Related]
35. Antiprogestins inhibit growth and stimulate differentiation in the normal mammary gland.
Li M; Spitzer E; Zschiesche W; Binas B; Parczyk K; Grosse R
J Cell Physiol; 1995 Jul; 164(1):1-8. PubMed ID: 7790381
[TBL] [Abstract][Full Text] [Related]
36. Endocrine and antitumor effects of combined treatment with an antiprogestin and antiestrogen or luteinizing hormone-releasing hormone agonist in female rats bearing mammary tumors.
Bakker GH; Setyono-Han B; Portengen H; De Jong FH; Foekens JA; Klijn JG
Endocrinology; 1989 Sep; 125(3):1593-8. PubMed ID: 2527151
[TBL] [Abstract][Full Text] [Related]
37. Effect of estrogens and antiestrogens on growth of human breast cancer cells in athymic nude mice.
Osborne CK; Hobbs K; Clark GM
Cancer Res; 1985 Feb; 45(2):584-90. PubMed ID: 3967234
[TBL] [Abstract][Full Text] [Related]
38. Effect of antiprogestins and tamoxifen on growth inhibition of MCF-7 human breast cancer cells in nude mice.
El Etreby MF; Liang Y
Breast Cancer Res Treat; 1998 May; 49(2):109-17. PubMed ID: 9696393
[TBL] [Abstract][Full Text] [Related]
39. Polyamines and hormonal regulation of N-nitrosomethylurea-induced rat mammary tumor growth in vivo.
Manni A; Wright C; Demers L; Luk G
Cancer Res; 1986 Oct; 46(10):4938-41. PubMed ID: 3756855
[TBL] [Abstract][Full Text] [Related]
40. Enhancement of the antitumor efficacy of the antiprogestin, onapristone, by combination with the antiestrogen, ICI 164384.
Nishino Y; Schneider MR; Michna H
J Cancer Res Clin Oncol; 1994; 120(5):298-302. PubMed ID: 8126059
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
